GP Healthcare Capital logo

GP Healthcare Capital

Asia, Shanghai, China, Shanghai

Description

GP Healthcare Capital is a venture capital that makes investments in companies based in the biotechnology industry.

Investor Profile

GP Healthcare Capital has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 50% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series B (50%)
  • Series Unknown (25%)
  • Series A (25%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Oncology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does GP Healthcare Capital frequently co-invest with?

CICC
Asia, Beijing, China, Beijing
Co-Investments: 1
GL Ventures LLC
Asia, Beijing, China, Beijing
Co-Investments: 1
China Asset Management
Asia, Beijing, China, Beijing
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
PICC Capital Investment Management
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CL
Asia, Beijing, China, Beijing
Co-Investments: 1
Forebright Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
FutureX Capital
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
CD Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
ABC International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1

What are some of recent deals done by GP Healthcare Capital?

Jenscare Biotech

Ningbo, Zhejiang, China

Ningbo Jenscare Scientific is a medical device company.

BiotechnologyHealth Care
Series UnknownMay 28, 2021
Laekna Therapeutics

Shanghai, Shanghai, China

Laekna Therapeutics is a biotech company focusing on drug discovery and development.

Biotechnology
Series BApr 2, 2019
Amount Raised: $27,500,000
GenomiCare Biotechnology

Shanghai, Shanghai, China

GenomiCare Biotechnology is a Chinese precision cancer medicine service company

BiotechnologyHealth Care
Series ADec 18, 2018
Amount Raised: $30,000,000
Adagene

Suzhou, Jiangsu, China

Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies.

BiotechnologyMedicalOncologyTherapeutics
Series BJan 29, 2016
Amount Raised: $28,000,000

Find More Investors Like GP Healthcare Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

GP Healthcare Capital | Pipeseed